Press
Press releases related to our research.
- Supercomputing Accelerates Path to Cancer Predictions and Treatment
- Quantitative bioinformatics studies utilizing genomics, proteomics and imaging experiments require the integration of vast amounts of data in order to gain new insights from large population data sets. In an effort to solve some of life science’s most complex questions, The Linding Laboratory in Denmark partnered with HPE/SGI to further its research at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen and extract deeper insights into areas such as cell and cancer biology using high performance computing (HPC).
- KU-forskere slår igennem med banebrydende kræftforskning
- GENNEMBRUD - Det anerkendte tidskrift CELL hylder KU-forskning i spritny publikation. Resultaterne kan ændre måden vi undersøger og behandler kræftpatienter på, siger laboratorieleder.
- Using Proteomics to Understand How Genetic Mutations Rewire Cancer Cells
- Scientific publications highlight studies using data from Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing to discover how cancer attacks the protein networks controlling human cells
- University of Copenhagen (UCPH) and Beckman Coulter Genomics (BCG) Collaborate to Unravel How Mutations Rewire Cancer Cells
- Through advanced genetic algorithms and supercomputing, scientists have discovered how genetic diseases such as cancer systematically attack the networks controlling human cells, according to a pair of papers published back-to-back in CELL
- University of Copenhagen Uses SGI Supercomputer to Decode How Mutations Rewire Cancer Cells
- Two landmark findings to be published in the premier life and biological sciences journal, Cell
- Digital ‘Rosetta Stone’ Decrypts How Mutations Rewire Cancer Cells
- CANCER GENOMICS: Scientists have discovered how genetic cancer mutations systematically attack the networks controlling human cells, knowledge critical for the future development of personalized precision cancer treatments.
- Super-computerprogram skal forudsige bedste kræftbehandling
- To patienter med samme type kræft kan have behov for hver sin behandling. Men hvilken behandling passer til hvem? Danske forskere har for første gang udviklet et computerprogram, der skal fortælle, hvad der er unikt ved hver enkelt kræftsygdom. Målet er at kunne forudsige, hvilken behandling hver enkelt kræftpatient skal have.
- Brystkræft - Ny viden vækker begejstring
- Coverage of our NATURE paper with the Erler Lab in National News Primetime (DR1, TV AVISEN, 1830 on May 29th 2015).
- Radio24/7: Prof Sommer and Linding on Future Medicine (in Danish)
- Når din læge stiller en diagnose, og når du bliver behandlet på sygehuset, sker det ofte i blinde. Vi ved nemlig i virkeligheden ikke særlig meget om de grundlæggende mekanismer i kroppens celler. Professor ved DTU, Rune Linding forsker i, om vi kan blive bedre til at forudsige, hvordan cellerne reagerer på forskellige lægemidler. Derfor har han inviteret professor Morten Sommer, som blandt andet forsker i antibiotikaresistens, til at diskutere, hvordan fremtidens sundhedsvæsen kommer til at se ud. Rune Linding, Morten Sommer
- DTU Team Testing Orbitrap Fusion's Phosphoproteomic Capabilities as Part of Thermo Collaboration
- Thermo Fisher Scientific and the Department of Systems Biology at the Technical University of Denmark last week announced a collaboration on technology and application development related to research into cellular protein signaling.
- Unique Protein and Peptide Identifications Increase 20% with New Nano-ESI Source
- When testing a new mass spectrometry source in its 24/7/365 operation, scientists at the C-SIG (Cellular Signal Integration Group) lab observed a 20% increase in peptide and protein identification. The C-SIG lab was one of very few labs worldwide to test the new Thermo Scientific EASY-Spray nano-electrospray ion source prior to product launch. It was installed on their Thermo Scientific Q Exactive mass spectrometer.
- Are companies drowing in a sea of data?
- FT look at how businesses are coming to terms with the growing volumes of data they have to collect and keep. And how technology is helping firms to translate those data into new, more accurate predictions and insights.
- Netværksmedicin – en lovende strategi mod bl.a. kræft
- Forskning i biologiske netværk er vejen frem mod ny medicin og bedre behandlingsstrategier for sygdomme som kræft, diabetes og neurologiske lidelser. DTU var vært, da verdens førende forskere i netværksbiologi for nylig mødtes i Danmark for at diskutere potentialet i netværksmedicin.
- Top Network Biologists Meet in Denmark to Discuss the Exciting Future of Network Medicine
- The Integrative Network Biology (INB) and The Technical University of Denmark (DTU). The theme of the symposium is the promising new research area of network medicine.
- Conquering Computational Complexities in Cancer Research
- Large Shared Memory and Big Dynamic Range Computing - Essential Drivers in Global Modeling of Cancer Cells
- Taler celler over hækken?
- Cellerne i vores krop kommunikerer med hinanden. Den mekanisme kan udnyttes, når vi skal forsøge at forstå dannelsen af livstruende sygdomme og på sigt give langt bedre behandling og forebyggelse.
- Forskere usikre på karrieren
- Gæsteprofessor Rune Linding (billedet) er netop vendt hjem til Danmark sammen med sin hustru efter ti års udlandsophold. LInding, der skal udføre et netværksmedicinsk studie af cancer på DTU, er en af de 33 yngre topforskere, som i dag tildeles midler af karriereprogrammet Sapere Aude.
- DTU Accelerates Metagenomic Research with SGI Altix UV
- SGI Altix UV is unique in its delivery of an extremely deep computational dynamic range, which enables CBS researchers to explore very large biological networks and sequence data.
- ICR Hosts Meeting of Top Network Biologists
- Experts from around the world will this week discuss the exciting new research area of network biology at a meeting hosted by Europe’s top cancer research institute.
- Scientists Hear Cell Conversation for First Time
- A cutting edge technique that allows scientists to monitor communication between cells could transform the way laboratory medical experiments are conducted.
- ICR Collaborates to Create State-of-the-Art Proteomics Laboratory
- Thermo Fisher Scientific Inc., the world leader in serving science, today announced a collaboration with the integrative network biology initiative at The Institute of Cancer Research (ICR), UK. The ICR’s new, state-of-the-art proteomics laboratory is equipped with a complete Thermo Scientific proteomics workflow, including the Kingfisher Flex automated sample preparation system, the TSQ Vantage™ triple quadrupole and the UK’s first two LTQ Orbitrap Velos™ mass spectrometers. This workflow provides powerful capabilities to meet the needs of the ICR’s demanding research goals.
- Human Cells Evolved to Reduce Cancer Risk
- The cells of humans and other animals have likely evolved to reduce the chance of triggering cancers and other diseases, according to research published in the journal Science.
- Network Tool Predicts Cancer Survival
- A woman’s chance of recovering from breast cancer can be predicted with more than 80 per cent accuracy, following the development of a new computer software called ‘DyNeMo’ that analyses changing patterns of protein activity within the body. These findings are reported in today’s Nature Biotechnology journal.
- Cancer Weaknesses Exposed by Computing
- Scientists have created innovative problem-solving software that highlights the weak points in cancers' 'signaling networks', creating the possibility for new cancer treatments, according to a paper being published in Science Magazine (17 October 2008)1.
- Supercomputing to Target Cancer Research
- The Altix UV supercomputer will allow extremely large, diverse data sets to be processed quickly, enabling our researchers to correlate medical and biological data on an unprecedented scale.
- Future Treatments May Target Shared Biological Networks
- Multiple complex human diseases can be traced back to errors in the same ancient biological networks, according to new research published as the cover story in the journal Science Signaling.
- Studier af cellers netværk kan være nøglen bedre at forstå og behandle kræft
- De færreste mennesker eller organisationer træffer livsvigtige beslutninger, som udelukkende er baseret på input fra én person. De fleste foretrækker at tale med flere om det, og afveje synspunkter fra venner, kollegaer og familie. Nyt forskningsprojekt bryder med medicinsk tradition og prøver at forstå kræftceller på samme måde ved at kortlægge, hvad der sker i deres signalnetværk, når de bliver til kræftceller. Resultatet kan ændre måden vi forebygger og behandler kræft på
- En ny forståelse af cancer
- Sapere Aude pris overrakt ved EliteForsk Konference 9. februar 2012: Rune Linding Rune Linding er blandt pionererne inden for netværksmedicin, og selv om hans arbejde både er innovativt og utroligt komplekst, så er de endelige målsætninger ganske konkrete og vigtige for os alle sammen: at formulere fundamentalt helt nye typer af medicin, som kan bruges i kampen mod cancer.